High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.4M
$10,356,403
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Equity Compensation
2025-12-04
$103,835x5
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Equity Compensation
|
2025-12-04 | $103,835x5 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 Sell
2025-12-04
$212,377
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 Sell
|
2025-12-04 | $212,377 | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-21
$2,501,922Largex6
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-21 | $2,501,922Largex6 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -51.0%
2025-11-21
$5,216,346Whale
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -51.0%
|
2025-11-21 | $5,216,346Whale | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
Other
2025-11-20
$1,962,637Largex2
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
Other
|
2025-11-20 | $1,962,637Largex2 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -50.1%
2025-11-20
$4,927,680Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -50.1%
|
2025-11-20 | $4,927,680Large | S | Form 4 |